IGF2 and ovarian cancer: In patients with epithelial ovarian cancer, loss of heterozygosity of both Igf2 and H19 genes tend to be found in advanced clinical stages of ovarian cancer, loss of imprinting of Igf2 and H19 genes may be contributed to the development of ovarian cancer [50].